\
&
Contact us
\
&
Contact us
Published on | 1 day ago
Programmes Climate, Energy, MobilityThe Maglev system (magnetic levitation) of rail transport has been in existence for a long time but has never known a breakthrough in the European Union because of a number of technological disavantages and a lack of adequate infrastructure.
The Joint Undertaking European Rail would like to further develop the maglev-derived systems and has therefore published a new call for proposals. The call is open untill the 7th of May 2025 and can be found on this webpage.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI, data & cloud Advanced Digital Skills Deployment: Best use of technologies
The upcoming calls from the Digital Europe Main Work Programme have been published on the Funding & Tenders Portal of the European Commission. The following 10 call topics are expected to open for submission on 15 April 2025, deadline to submit proposals will be 2 September 2025: AI, data & cloud Apply AI: GenAI for the public ad... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
